Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  selenium
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-22 of 22 for your search:
Start Over
S0000 Selenium and Vitamin E in Preventing Prostate Cancer
Phase: Phase III
Type: Prevention
Status: Closed
Age: 55 and over (50 and over for African Americans)
Sponsor: NCI, Other
Protocol IDs: CDR0000068277, S0000, U10CA037429, SWOG-S0000, CAN-NCIC-S0000, CALGB-S0000, ECOG-S0000, NCCAM, NCI-P00-0172, NCT00006392
Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000068402, ECOG-5597, CAN-NCIC-BR16, CALGB-79803, NCCTG-E5597, SWOG-E5597, NCI-P00-0176, E5597, BR16, NCT00008385
S9917, Selenium in Preventing Cancer in Patients With Neoplasia of the Prostate
Phase: Phase III
Type: Prevention
Status: Completed
Age: 40 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000069210, U10CA037429, S9917, CALGB-70004, NCI-P02-0203, SWOG-S9917, ECOG-SWOG-S9917, NCT00030901
Study of the Effect of Nutritional Intervention on Esophageal Cancer in Linxian, People's Republic of China (Summary Last Modified 10/88)
Phase: Phase III
Type: Prevention
Status: Completed
Age: 40 to 69
Sponsor:
Protocol IDs: DCPC-CPSB-11204
Selenium for Prevention of Adenomatous Colorectal Polyps
Phase: Phase III
Type: Prevention
Status: Closed
Age: 40 to 80
Sponsor: NCI, Other
Protocol IDs: CDR0000353185, P30CA023074, P01CA041108, UARIZ-00-0430-01, 00-0430-01, UARIZ-HSC-00142, NCT00078897
S0000D: Effect of Vitamin E and/or Selenium on Colorectal Polyps in Men Enrolled on SELECT Trial SWOG-S0000
Phase: Phase III
Type: Natural history/Epidemiology, Prevention
Status: Closed
Age: 50 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000593329, S0000D, U10CA037429, SWOG-S0000D, NCT00706121
Vitamin E, Selenium, and Soy Protein in Preventing Cancer in Patients With High-Grade Prostate Neoplasia
Phase: Phase III
Type: Prevention
Status: Completed
Age: Not specified
Sponsor: Other
Protocol IDs: PRP1, CAN-NCIC-PRP1, CDR0000310096, NCT00064194
Selenium in Preventing Prostate Cancer
Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: Under 80
Sponsor: NCI, Other
Protocol IDs: 01-0506-01, R01CA077789, P30CA023074, UARIZ-99-0045-01,, 99-0045-01, NCT00978718
S0000C Vitamin E and/or Selenium in Preventing Loss of Lung Function in Older Men Enrolled on SELECT Clinical Trial SWOG-S0000
Phase: Phase III
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology
Status: Completed
Age: 55 and over (50 and over for African Americans)
Sponsor: NCI, Other
Protocol IDs: CDR0000617786, U10CA012027, S0000C, U10CA037429, SWOG-S0000C, NCT00782678
Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE)
Phase: Phase III
Type: Natural history/Epidemiology
Status: Closed
Age: 60 to 90
Sponsor: NCI, Other
Protocol IDs: IA0033, 5R01AG019241, SWOG-S0000A, S0000A, NCT00780689, NCT00040378
Phase II Pilot Randomized Study of Selenium Versus Observation Only Before Radical Prostatectomy in Patients With Primary Adenocarcinoma of the Prostate
Phase: Phase II
Type: Prevention, Treatment
Status: Completed
Age: Not specified
Sponsor: NCI
Protocol IDs: SWOG-S9812, NCI-P01-0182
The Use of Selenium to Treat Secondary Lymphedema - Breast Cancer
Phase: Phase II
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: UHN REB 03-0741-C, NCT00188604
Selenium in Treating Patients With Prostate Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: Under 85
Sponsor: NCI, Other
Protocol IDs: 97-0395-01, R01CA079080, P30CA023074, UARIZ-97-0395, UARIZ-HSC-97-57, DAMD17-98-1-8580, Watchful Waiting, NCT00752739
Phase I Randomized Study of Selenium With or Without Vitamin E for the Prevention of Lung Cancer in Smokers (Summary Last Modified 11/2000)
Phase: Phase I
Type: Prevention
Status: Closed
Age: 18 to 70
Sponsor: NCI
Protocol IDs: KUMC-7159-97, NCI-P00-0152
Irinotecan and Selenium in Treating Patients With Advanced Solid Tumors
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000427616, RPCI-I-32804, NCT00112892
Selenium in Treating Patients Who Are Undergoing Brachytherapy for Stage I or Stage II Prostate Cancer
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: Any age
Sponsor: NCI, Other
Protocol IDs: CDR0000441225, P30CA016056, RPCI-I-14603, NCT00217516
Pilot Randomized Chemoprevention Study of Selenium and Celecoxib, Alone or in Combination, in Patients With Esophageal Squamous Dysplasia Who are Residing in Linxian, People's Republic of China
Phase: No phase specified
Type: Prevention
Status: Closed
Age: 40 to 69 at time of screening
Sponsor: NCI
Protocol IDs: NCI-OH95-C-N026, NCI-P00-0157, NCT00005885
Selenium in the Prevention of Cancer
Phase: No phase specified
Type: Prevention
Status: Closed
Age: 60 to 74
Sponsor: Other
Protocol IDs: CDR0000068791, SURREY-UK-PRECISE, EU-20113, NCT00022165
Selenium and Prostate Cancer: Clinical Trial on Availability to Prostate Tissue and Effects on Gene Expression
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: Not specified
Sponsor: Other
Protocol IDs: WCRF 2004/21, CMO nr. 2007/003, SePros 2006/02, NL14694.091.07, NCT00446901
Soy, Selenium and Breast Cancer Risk
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 35 to 50
Sponsor: Other
Protocol IDs: R14697, 07/Q0101/10, NCT00555386
Start Over